Mamkulathil Devasia R, Altaf M, Alrefaei A, Manoharadas S
J King Saud Univ Sci. 2021; 33(2):101344.
PMID: 33531790
PMC: 7826111.
DOI: 10.1016/j.jksus.2021.101344.
Li F, Jiang T, Li Q, Ling X
Am J Cancer Res. 2018; 7(12):2350-2394.
PMID: 29312794
PMC: 5752681.
Zare-Mirakabadi A, Sarzaeem A, Moradhaseli S, Sayad A, Negahdary M
Iran J Cancer Prev. 2015; 5(3):109-16.
PMID: 25628829
PMC: 4294532.
Pommier Y, Barcelo J, Rao V, Sordet O, Jobson A, Thibaut L
Prog Nucleic Acid Res Mol Biol. 2006; 81:179-229.
PMID: 16891172
PMC: 2576451.
DOI: 10.1016/S0079-6603(06)81005-6.
Ulukan H, Swaan P
Drugs. 2002; 62(14):2039-57.
PMID: 12269849
DOI: 10.2165/00003495-200262140-00004.
Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.
Storm P, Moriarity J, Tyler B, Burger P, Brem H, Weingart J
J Neurooncol. 2002; 56(3):209-17.
PMID: 12061726
DOI: 10.1023/a:1015003232713.
Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma.
Yanase K, Sugimoto Y, Tsukahara S, Andoh T, Tsuruo T
Jpn J Cancer Res. 2000; 91(5):551-9.
PMID: 10835501
PMC: 5926386.
DOI: 10.1111/j.1349-7006.2000.tb00980.x.
Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.
Gerrits C, De Jonge M, Schellens J, Stoter G, Verweij J
Br J Cancer. 1997; 76(7):952-62.
PMID: 9328159
PMC: 2228255.
DOI: 10.1038/bjc.1997.491.
Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity.
Morris E, Geller H
J Cell Biol. 1996; 134(3):757-70.
PMID: 8707853
PMC: 2120941.
DOI: 10.1083/jcb.134.3.757.
Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription.
Dreyfuss G, Adam S, Choi Y
Mol Cell Biol. 1984; 4(3):415-23.
PMID: 6717428
PMC: 368718.
DOI: 10.1128/mcb.4.3.415-423.1984.
Mitochondrial protein synthesis: RNA with the properties of Eukaryotic messenger RNA.
Perlman S, Abelson H, Penman S
Proc Natl Acad Sci U S A. 1973; 70(2):350-3.
PMID: 4510280
PMC: 433256.
DOI: 10.1073/pnas.70.2.350.
Antiviral action of camptothecin.
Horwitz S, Chang C, Grollman A
Antimicrob Agents Chemother. 1972; 2(5):395-401.
PMID: 4363789
PMC: 444326.
DOI: 10.1128/AAC.2.5.395.
Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.
Andoh T, Ishii K, Suzuki Y, Ikegami Y, Kusunoki Y, Takemoto Y
Proc Natl Acad Sci U S A. 1987; 84(16):5565-9.
PMID: 3039492
PMC: 298903.
DOI: 10.1073/pnas.84.16.5565.
Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin.
Thomsen B, Mollerup S, Bonven B, Frank R, Blocker H, Nielsen O
EMBO J. 1987; 6(6):1817-23.
PMID: 3038537
PMC: 553560.
DOI: 10.1002/j.1460-2075.1987.tb02436.x.
Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.
Tamura H, Kohchi C, Yamada R, Ikeda T, Koiwai O, Patterson E
Nucleic Acids Res. 1991; 19(1):69-75.
PMID: 1849260
PMC: 333535.
DOI: 10.1093/nar/19.1.69.
Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium.
Greene L
J Cell Biol. 1978; 78(3):747-55.
PMID: 701359
PMC: 2110184.
DOI: 10.1083/jcb.78.3.747.
Failure to detect "cap" structures in mitochondrial DNA-coded poly(A)-containing RNA from HeLa cells.
Grohmann K, Amairic F, Crews S, Attardi G
Nucleic Acids Res. 1978; 5(3):637-51.
PMID: 643614
PMC: 342012.
DOI: 10.1093/nar/5.3.637.
